TITA

COM:TITANBIOTECHLTD

Titan Biotech Ltd.

  • Stock

Last Close

893.60

08/11 09:03

Market Cap

4.96B

Beta: -

Volume Today

6.66K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
391.34M
-
403.16M
3.02%
457.70M
13.53%
526.92M
15.12%
573.74M
8.89%
649.08M
13.13%
794.38M
22.39%
1.42B
79.05%
1.53B
7.43%
1.44B
5.77%
1.64B
13.94%
cost of revenue
302.59M
-
300.92M
0.55%
339.48M
12.81%
401.80M
18.36%
384.64M
4.27%
403.73M
4.96%
476.38M
17.99%
752.84M
58.03%
748.76M
0.54%
698.73M
6.68%
1.03B
46.90%
gross profit
88.75M
-
102.24M
15.20%
118.23M
15.63%
125.12M
5.83%
189.10M
51.14%
245.35M
29.74%
318.00M
29.61%
669.54M
110.54%
779.33M
16.40%
741.26M
4.89%
614.25M
17.13%
selling and marketing expenses
1.01M
-
1.80M
78.14%
22.76M
1,162.23%
26.78M
17.62%
27.33M
2.07%
35.33M
29.26%
42.79M
21.14%
58.66M
37.07%
general and administrative expenses
33.96M
-
1.27M
96.27%
1.13M
10.74%
7.69M
579.13%
8.58M
11.65%
11.93M
39.06%
11.00M
7.80%
15.06M
36.87%
22.48M
49.25%
selling general and administrative expenses
33.96M
-
2.28M
93.28%
2.94M
28.71%
30.45M
937.38%
35.36M
16.11%
39.26M
11.05%
46.33M
18.00%
57.86M
24.88%
81.14M
40.24%
94.25M
16.16%
304.74M
223.33%
research and development expenses
237.59K
-
276.11K
16.21%
914.83K
231.33%
346.15K
62.16%
460.58K
33.06%
408.21K
11.37%
1.01M
147.41%
967.01K
4.25%
other expenses
3.82M
-
3.98M
4.36%
5.48M
37.54%
2.76M
49.71%
201.44K
92.69%
126.71K
37.10%
258.72K
104.18%
1.31M
404.72%
10.22M
683.03%
19.43M
90.05%
17.48M
10.04%
cost and expenses
367.73M
-
372.61M
1.33%
426.24M
14.39%
480.61M
12.76%
513.23M
6.79%
575.14M
12.06%
676.98M
17.71%
978.63M
44.56%
1.14B
16.85%
1.17B
2.39%
1.33B
13.70%
operating expenses
65.14M
-
71.69M
10.06%
86.76M
21.02%
78.81M
9.16%
128.60M
63.17%
171.41M
33.29%
200.60M
17.03%
225.80M
12.56%
394.75M
74.83%
472.07M
19.59%
304.74M
35.45%
interest expense
2.36M
-
8.57M
263.66%
7.27M
15.22%
13.17M
81.15%
22.34M
69.67%
21.69M
2.88%
20.62M
4.97%
14.79M
28.24%
12.83M
13.31%
7.46M
41.84%
11.70M
56.86%
ebitda
34.04M
-
41.57M
22.13%
41.59M
0.04%
55.43M
33.29%
72.68M
31.12%
96.25M
32.43%
136.88M
42.21%
471.32M
244.33%
420.19M
10.85%
314.62M
25.12%
342.81M
8.96%
operating income
25.84M
-
33.18M
28.42%
30.90M
6.87%
45.64M
47.69%
60.43M
32.39%
72.13M
19.36%
116.82M
61.97%
438.42M
275.28%
292.44M
33.30%
274.25M
6.22%
309.51M
12.85%
depreciation and amortization
8.20M
-
8.38M
2.31%
7.71M
8.09%
8.16M
5.85%
9.32M
14.24%
17.12M
83.67%
18.00M
5.18%
22.17M
23.17%
25.38M
14.48%
26.00M
2.44%
33.31M
28.09%
total other income expenses net
-3.50M
-
-8.68M
147.91%
-4.39M
49.42%
-12.16M
176.77%
-19.77M
62.58%
-17.07M
13.64%
-13.05M
23.57%
-11.94M
8.48%
-3.88M
67.50%
6.46M
266.60%
5.78M
10.55%
income before tax
22.34M
-
24.50M
9.68%
26.51M
8.21%
33.49M
26.31%
41.00M
22.43%
55.44M
35.23%
104.04M
87.66%
427.06M
310.46%
381.98M
10.55%
281.16M
26.39%
315.29M
12.14%
income tax expense
7.42M
-
8.18M
10.26%
8.83M
7.94%
11.68M
32.25%
14.32M
22.59%
16.32M
13.98%
25.67M
57.30%
110.00M
328.56%
96.45M
12.32%
70.92M
26.47%
78.66M
10.91%
net income
14.92M
-
16.32M
9.39%
17.68M
8.35%
21.81M
23.34%
25.43M
16.61%
35.22M
38.51%
70.66M
100.60%
303.35M
329.33%
255.23M
15.86%
248.44M
2.66%
248.53M
0.04%
weighted average shs out
7.04M
-
7.74M
9.95%
7.74M
0%
7.74M
0%
7.74M
0%
8.26M
6.78%
8.26M
0%
8.26M
0%
8.26M
0%
8.26M
0%
8.26M
0%
weighted average shs out dil
7.04M
-
7.74M
9.95%
7.74M
0%
7.74M
0%
7.74M
0%
8.26M
6.78%
8.26M
0%
8.26M
0%
8.26M
0%
8.26M
0%
8.26M
0%
eps
2.12
-
2.11
0.47%
2.29
8.53%
2.82
23.14%
3.29
16.67%
4.26
29.48%
8.55
100.70%
36.71
329.36%
26.24
28.52%
30.06
14.56%
30.07
0.03%
epsdiluted
2.12
-
2.11
0.47%
2.28
8.06%
2.82
23.68%
3.29
16.67%
4.26
29.48%
8.55
100.70%
36.71
329.36%
26.24
28.52%
30.06
14.56%
30.07
0.03%

All numbers in (except ratios and percentages)